OSR Holdings, Inc. (NASDAQ:OSRH) Sees Large Decrease in Short Interest

OSR Holdings, Inc. (NASDAQ:OSRH) saw a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling 872,385 shares, a drop of 26.0% from the November 30th total of 1,178,892 shares. Based on an average daily volume of 601,598 shares, the short-interest ratio is presently 1.5 days. Approximately 8.6% of the shares of the company are short sold. Approximately 8.6% of the shares of the company are short sold. Based on an average daily volume of 601,598 shares, the short-interest ratio is presently 1.5 days.

Wall Street Analysts Forecast Growth

OSRH has been the topic of a number of recent analyst reports. Wall Street Zen upgraded OSR to a “sell” rating in a research note on Saturday, October 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OSR in a research report on Monday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

OSR Trading Up 0.6%

NASDAQ:OSRH traded up $0.00 during mid-day trading on Tuesday, hitting $0.58. The company’s stock had a trading volume of 361,981 shares, compared to its average volume of 3,770,899. The company has a market capitalization of $14.81 million, a price-to-earnings ratio of -0.52 and a beta of 1.33. OSR has a fifty-two week low of $0.45 and a fifty-two week high of $12.54. The stock has a fifty day moving average of $0.62 and a 200-day moving average of $0.77.

OSR (NASDAQ:OSRH) last released its quarterly earnings data on Wednesday, November 12th. The company reported ($0.10) earnings per share for the quarter. The firm had revenue of $0.63 million during the quarter.

Institutional Trading of OSR

An institutional investor recently bought a new position in OSR stock. Susquehanna International Group LLP acquired a new position in shares of OSR Holdings, Inc. (NASDAQ:OSRH) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 79,807 shares of the company’s stock, valued at approximately $43,000. Susquehanna International Group LLP owned approximately 0.37% of OSR as of its most recent filing with the Securities and Exchange Commission. 55.30% of the stock is currently owned by institutional investors and hedge funds.

OSR Company Profile

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials.